PL
Psyence Labs Ltd disclosed a 49.8% stake in PBM
Psyence Labs Ltd reported owning 49.8% of Psyence Biomedical Ltd. (PBM) (2,643,659 shares) in a Schedule 13D filed Oct 15, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13D